Compare SEB & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SEB | RLAY |
|---|---|---|
| Founded | 1918 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.1B |
| IPO Year | 1994 | 2020 |
| Metric | SEB | RLAY |
|---|---|---|
| Price | $4,055.01 | $18.04 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $27.58 |
| AVG Volume (30 Days) | 8.1K | ★ 3.1M |
| Earning Date | 10-27-2026 | 11-05-2026 |
| Dividend Yield | ★ 0.22% | N/A |
| EPS Growth | ★ 467.71 | 31.78 |
| EPS | ★ 283.99 | N/A |
| Revenue | ★ $5,809,000,000.00 | $15,355,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $60.73 |
| P/E Ratio | $14.51 | ★ N/A |
| Revenue Growth | 7.99 | ★ 53.44 |
| 52 Week Low | $3,140.01 | $5.85 |
| 52 Week High | $5,989.37 | $21.27 |
| Indicator | SEB | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 44.43 | 44.94 |
| Support Level | $3,850.01 | $17.83 |
| Resistance Level | $4,391.67 | $20.54 |
| Average True Range (ATR) | 134.41 | 0.98 |
| MACD | -0.62 | 0.04 |
| Stochastic Oscillator | 32.55 | 36.36 |
Seaboard Corp is a diversified group of companies that operate in agricultural, energy, and ocean transport businesses. The company is engaged in hog production, biofuel production, and pork processing in the United States; commodity trading and grain processing in Africa and South America; cargo shipping services in the U.S., Caribbean and Central and South America; sugar and alcohol production in Argentina; and electric power generation in the Dominican Republic. It also has an equity method investment in Butterball, LLC, a producer and processor of turkey products. The group's operating segments are; pork, commodity trading and milling, marine, liquid fuels, power, turkey, and others. It operates in 45 countries, with a concentration in the Caribbean, Central and South American region.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.